Table 1:
Classification and regulatory pathways for approved diabetic wound products.
| Product | Description | Classification | Regulatory pathway |
|---|---|---|---|
| TegasorbTM | Hydrocolloid dressing | Device | 510 (K) pre-market notification |
| Hyalomatrix® | Hyaluronic acid derivative hydrogel | Device | 510 (K) pre-market notification |
| Regranex® | Hydrogel with platelet derived growth factor | Drug | NDA |
| DermACELL® | Acellular human cadaver derived matrix | Device | HCT/P |
| ActicoatTM | Silver incorporated polymer matrix | Combination device, FRO | 510 (K) pre-market notification |